Vimarsana
Biggest News Aggregation in the World

Minute Walk Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Minute Walk Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Minute Walk Test Today - Breaking & Trending Today

Doing daily chores around the house is best activity for individuals recovering from COVID-19, say scientists - Vimarsana News

Doing daily chores around the house is best activity for individuals recovering from COVID-19, say scientists

Patients with COVID-19 have the best chance to recover if they continue performing their daily household chores like cooking, eating, dressing, and keeping good hygiene, scientists have found.

Should Therapy for Disabling Low Back Pain in Older Patients Focus on the Hips? - Vimarsana News

Should Therapy for Disabling Low Back Pain in Older Patients Focus on the Hips?

Tailored hip-based physical therapy yielded superior outcomes vs spine-focused treatment in older patients.

Researchers use a soft, wearable robot to help a person living with Parkinson's walk without freezing - Vimarsana News

Researchers use a soft, wearable robot to help a person living with Parkinson's walk without freezing

Researchers demonstrated the effectiveness of soft robotic apparel in averting Freezing of Gait (FoG) in Parkinson's disease (PD) patients, showcasing significant improvements in mobility and gait quality.

SMA May Be Linked to Cognitive Impairment in Chinese Patients - Vimarsana News

SMA May Be Linked to Cognitive Impairment in Chinese Patients

A cross-sectional study suggests that spinal muscular atrophy (SMA) can contribute to cognitive impairment.

Source: ajmc.com
Alnylam Announces Publication of Results from APOLLO-B Phase 3 Study of Patisiran in Patients with the Cardiomyopathy of ATTR Amyloidosis in the New England Journal of Medicine - Vimarsana News

Alnylam Announces Publication of Results from APOLLO-B Phase 3 Study of Patisiran in Patients with the Cardiomyopathy of ATTR Amyloidosis in the New England Journal of Medicine

– Treatment with an RNAi Therapeutic Preserved Functional Capacity and Health Status and Quality of Life Compared with Placebo at 12 Months – – Patisiran Demonstrated an Encouraging Safety...